Microtech Medical
Financials
Estimates*
CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 75.3m | 151m | 174m | 248m | 377m | 576m | 813m |
% growth | 45 % | 101 % | 15 % | 43 % | 52 % | 53 % | 41 % |
EBITDA | (121m) | (39.8m) | (21.7m) | (115m) | (110m) | (39.7m) | 27.6m |
% EBITDA margin | (161 %) | (26 %) | (13 %) | (46 %) | (29 %) | (7 %) | 3 % |
Profit | (121m) | (48.2m) | (35.0m) | (125m) | (71.5m) | (9.2m) | 43.6m |
% profit margin | (161 %) | (32 %) | (20 %) | (50 %) | (19 %) | (2 %) | 5 % |
EV / revenue | - | 44.0x | 9.4x | 2.3x | -0.6x | -0.3x | -0.0x |
EV / EBITDA | - | -167.3x | -74.8x | -5.0x | 2.0x | 3.7x | -1.2x |
R&D budget | 82.0m | 14.8m | 30.6m | 70.1m | - | - | - |
R&D % of revenue | 109 % | 10 % | 18 % | 28 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Series A | ||
CNY160m | Series A | ||
N/A | Series A | ||
$3.7m | Series C | ||
CNY202m | Series C | ||
CNY141m | Late VC | ||
CNY575m | Late VC | ||
N/A | $249m | IPO | |
Total Funding | $152m |
Recent News about Microtech Medical
EditMicrotech Medical Devices specializes in providing advanced point-of-care diagnostic solutions, primarily through its IVocare POCT systems. The company serves healthcare providers and medical institutions, offering tools that enable rapid and accurate medical testing at the patient's bedside. Operating in the medical diagnostics market, Microtech leverages its proprietary Mountor technology to enhance the performance and reliability of its products. The business model revolves around the sale of diagnostic devices and related software, generating revenue through direct sales and long-term service agreements. Microtech's solutions are designed to improve patient outcomes by facilitating timely and precise diagnostics, thereby supporting better clinical decision-making.
Keywords: point-of-care, diagnostics, medical testing, healthcare, IVocare POCT, Mountor technology, rapid testing, medical devices, patient outcomes, clinical decision-making.